chrX-100402661-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001184880.2(PCDH19):āc.2479C>Gā(p.Arg827Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,209,935 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.0000018 ( 0 hom. 1 hem. )
Consequence
PCDH19
NM_001184880.2 missense
NM_001184880.2 missense
Scores
4
8
5
Clinical Significance
Conservation
PhyloP100: 2.69
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH19 | NM_001184880.2 | c.2479C>G | p.Arg827Gly | missense_variant | 3/6 | ENST00000373034.8 | NP_001171809.1 | |
PCDH19 | NM_001105243.2 | c.2338C>G | p.Arg780Gly | missense_variant | 2/5 | NP_001098713.1 | ||
PCDH19 | NM_020766.3 | c.2338C>G | p.Arg780Gly | missense_variant | 2/5 | NP_065817.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH19 | ENST00000373034.8 | c.2479C>G | p.Arg827Gly | missense_variant | 3/6 | 1 | NM_001184880.2 | ENSP00000362125.4 | ||
PCDH19 | ENST00000255531.8 | c.2338C>G | p.Arg780Gly | missense_variant | 2/5 | 1 | ENSP00000255531.7 | |||
PCDH19 | ENST00000420881.6 | c.2338C>G | p.Arg780Gly | missense_variant | 2/5 | 1 | ENSP00000400327.2 | |||
PCDH19 | ENST00000636150.1 | c.66-86C>G | intron_variant | 5 | ENSP00000490463.1 |
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112153Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34315
GnomAD3 genomes
AF:
AC:
1
AN:
112153
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34315
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 181422Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67314
GnomAD3 exomes
AF:
AC:
2
AN:
181422
Hom.:
AF XY:
AC XY:
1
AN XY:
67314
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1097782Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363154
GnomAD4 exome
AF:
AC:
2
AN:
1097782
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
363154
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112153Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34315
GnomAD4 genome
AF:
AC:
1
AN:
112153
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34315
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 01, 2018 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with PCDH19-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with glycine at codon 827 of the PCDH19 protein (p.Arg827Gly). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and glycine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;N;D
REVEL
Uncertain
Sift
Benign
T;D;D
Sift4G
Uncertain
D;D;D
Polyphen
0.83, 0.65
.;P;P
Vest4
MutPred
0.46
.;Gain of sheet (P = 0.0149);.;
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at